• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSB2300060 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Supplementary Application 2023-05-16 view
JXSL2000218 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Import Drug Application 2020-12-10 AbbVie Inc. Abbvie Inc In Review 2020-12-09 view
JXSB2000054 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Supplementary Application 2020-12-25 AbbVie Inc. Abbvie Inc In Review 2021-05-09 view
JXSB2300059 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Supplementary Application 2023-05-16 view
JXSB2000055 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Supplementary Application 2020-12-25 AbbVie Inc. Abbvie Inc In Review 2021-05-09 view
JXSB2300061 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Supplementary Application 2023-05-16 view
JXSL2000219 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Import Drug Application 2020-12-10 AbbVie Inc. Abbvie Inc In Review 2020-12-09 view